20/20 Biolabs (AIDX) vs Autonomix Medical (AMIX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Autonomix Medical is the larger company by market cap ($6.1 million vs $5.0 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AIDX | AMIX |
|---|---|---|
| Share price | $0.3878 | $3.12 |
| Market cap | $4.95M | $6.11M |
| 1-day change | +2.44% | -0.34% |
| EPS (TTM) | $-0.75 | $-39.67 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $50.00 | $32.55 |
| 52-week low | $0.33 | $2.44 |
| Distance from 52-week high | -99.22% | -90.42% |
| Analyst consensus | none | none |
| Avg. price target upside | +1189.32% | +1784.98% |
| Average volume | 90.86K | 4.50M |
| Shares outstanding | 12.77M | 1.96M |
| Employees | 4 | — |
| Sector | Health Care | Health Care |
| Industry | Precision Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About 20/20 Biolabs
AIDX stock →20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases.
Health Care · Precision Instruments · 4 employees
About Autonomix Medical
AMIX stock →Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system.
Health Care · Medical/Dental Instruments
AIDX vs AMIX FAQ
Which is bigger, 20/20 Biolabs or Autonomix Medical?
Autonomix Medical (AMIX) is larger, with a market capitalization of $6.11M compared with $4.95M for 20/20 Biolabs (AIDX).
Are 20/20 Biolabs and Autonomix Medical in the same industry?
Both are in the Health Care sector, but in different industries: Precision Instruments for 20/20 Biolabs and Medical/Dental Instruments for Autonomix Medical.